The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites.

They can be transmitted through direct contact with an infected person, animal, insect bites, or contaminated food and water.

Symptoms vary but often include fever, fatigue, muscle aches, cough, and digestive issues.

Diagnosis involves physical examinations, medical history review, and diagnostic tests such as blood tests, cultures, and imaging.

Treatments may include antibiotics, antivirals, antifungals, antiparasitics, and supportive care depending on the type of infection.

Common reasons include chronic sinusitis, nasal polyps, blocked sinus passages, and recurrent sinus infections that do not respond to other treatments.